Federal workers' families lose health coverage for gender care

What it does

This bill amends the Federal Employees Health Benefits (FEHB) program to prohibit coverage of gender-affirming medical care—including hormone therapy, puberty blockers, and surgical procedures—for individuals under 18 years old. It carves out exceptions for intersex conditions, treatment of complications from prior medical interventions, life-threatening emergencies, and standard puberty treatments for precocious or delayed puberty. Minors already receiving covered hormone therapy as of the bill's enactment may continue for up to one year on a physician-supervised reduction schedule.

Why we flagged it

The bill's operative mechanism is a categorical exclusion from federal employee health insurance for a specific class of medical treatment for minors. It is not a safety measure, transparency requirement, or fraud prevention—it is a coverage denial.

What the text implies

• The bill applies only to FEHB (federal employee plans), not to Medicare, Medicaid, or private insurance, creating a two-tier system where federal workers' families have fewer treatment options than other Americans—potentially incentivizing federal employees to seek private coverage or out-of-pocket care.
• The one-year wind-down provision for minors already in treatment may force abrupt cessation of ongoing medical care, creating medical and psychological discontinuity for vulnerable patients mid-treatment.

The full analysis lists 5 implications of this text.

Who it affects

The bill restricts access to a category of medical care for a vulnerable population (minors) by removing it from federal employee health plans, reducing treatment options available to federal workers' families and potentially setting a precedent for other public and private insurers. The carve-outs for intersex and emergency conditions are narrow and do not offset the broad exclusion.